Principaux concurrents
Rendement du dividende (Y) Rendement du dividende (Y+1) PER (Y) Price to Book (Y) VE / CA (Y) VE / EBITDA (Y) VE / EBIT (Y) Capi.($)
- - - - - - - 0
0,51%0,58%18.09x2.32x4.1x9.64x11.26x 76,15 Md
0,65%0,67%22.95x3.46x4.92x14.38x18.3x 48,89 Md
-.--%-.--%36.16x7.44x12.36x23.52x27.52x 47,83 Md
3,29%3,38%-46.27x2.57x3.25x9.61x11.21x 41,37 Md
-.--%-.--%37.23x1.65x3.36x12.07x13.84x 29,99 Md
-.--%-.--%55.01x4.08x3.36x26.05x23.16x 24,23 Md
-.--%-.--%-6.3x4.31x8.96x-5.6x-5.26x 21,89 Md
-.--%0,05%63.91x5.61x6.11x41.98x48.5x 19,25 Md
-.--%-.--%24.69x3.63x5.29x13.78x19.15x 17,14 Md
-.--%-.--%-36x-6.39x17.16x-46.97x-54.28x 15,66 Md
-.--%-.--%17.77x - 3.64x14.09x16.45x 11,6 Md
0,17%0,17%56.44x23.02x34.19x48.35x49.87x 11,5 Md
-.--%-.--%-104.97x11546.08x11.34x-81.23x-112.11x 11,22 Md
-.--%-.--%46.54x - - - - 10,06 Md
2,76%3,01%12.69x1.17x1.89x7.64x10.3x 6,84 Md
0,35%0,41%29.58x - 7.98x21.16x25.28x 6,06 Md
-.--%-.--%58.85x7.27x5.73x31.69x42.68x 5,8 Md
-.--%-.--%-116.26x - - - - 5,73 Md
Moyenne 0,43% 0,46% 9,45x 829,02x 8,35x 8,76x 9,12x 21,64 Md
Moyenne pondérée par Capi. 0,56% 0,59% 14,11x 346,69x 7,06x 10,90x 12,10x
Biopharmacies